Literature DB >> 12648838

Listeriosis: therapeutic options.

Herbert Hof1.   

Abstract

Since overt listeriosis occurs mainly in immunocompromised persons it is quite consistent to try to restore the hampered defence system by supportive measurements. For direct antimicrobial treatment a series of different antibiotics is available, since Listeria strains isolated from patients are in general susceptible to a wide range of antibiotics, except fosfomycin, quinolones and cephalosporins of the third generation, although a few exceptional strains exist. Unfortunately, most antibiotics are not bactericidal for Listeria. Drug combinations may exert a synergistic effect. Furthermore, the efficacy of therapy is limited by the fact of intracellular habitat of pathogenic Listeria. Few agents, such as macrolides and quinolones, are accumulated within host cells and may attack the intracellular Listeriae. The clinical experience shows that the combination of amoxicillin and gentamicin is the best option.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12648838     DOI: 10.1016/S0928-8244(02)00466-2

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  20 in total

1.  The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.

Authors:  Barry Collins; Nicola Curtis; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Antimicrob Agents Chemother       Date:  2010-07-19       Impact factor: 5.191

Review 2.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

3.  Systemic Listeria monocytogenes infection in a 2-year-old immunocompetent child.

Authors:  D Lobotková; E Dická; V Rolný; I Stankovič; P Čižnár
Journal:  Infection       Date:  2014-07-25       Impact factor: 3.553

4.  Antimicrobial resistance of Listeria monocytogenes strains isolated from humans in France.

Authors:  A Morvan; C Moubareck; A Leclercq; M Hervé-Bazin; S Bremont; M Lecuit; P Courvalin; A Le Monnier
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

5.  Bactericidal antibiotics do not appear to cause oxidative stress in Listeria monocytogenes.

Authors:  Louise Feld; Gitte M Knudsen; Lone Gram
Journal:  Appl Environ Microbiol       Date:  2012-04-13       Impact factor: 4.792

6.  The VirAB-VirSR-AnrAB Multicomponent System Is Involved in Resistance of Listeria monocytogenes EGD-e to Cephalosporins, Bacitracin, Nisin, Benzalkonium Chloride, and Ethidium Bromide.

Authors:  Xiaobing Jiang; Yimin Geng; Siyu Ren; Tao Yu; Yi Li; Guosheng Liu; Hailei Wang; Hecheng Meng; Lei Shi
Journal:  Appl Environ Microbiol       Date:  2019-10-01       Impact factor: 4.792

7.  Meropenem therapy failure in Listeria monocytogenes infection.

Authors:  S Stepanović; G Lazarević; M Jesić; R Kos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-13       Impact factor: 3.267

8.  Penicillin-binding proteins (PBP) and Lmo0441 (a PBP-like protein) play a role in Beta-lactam sensitivity of Listeria monocytogenes.

Authors:  Sébastien Van de Velde; Stéphane Carryn; Françoise Van Bambeke; Colin Hill; Paul M Tulkens; Roy D Sleator
Journal:  Gut Pathog       Date:  2009-12-15       Impact factor: 4.181

9.  Identification of a ferritin-like protein of Listeria monocytogenes as a mediator of β-lactam tolerance and innate resistance to cephalosporins.

Authors:  Agata Krawczyk-Balska; Julia Marchlewicz; Dorota Dudek; Katarzyna Wasiak; Anna Samluk
Journal:  BMC Microbiol       Date:  2012-11-24       Impact factor: 3.605

10.  Discrete and overlapping functions of peptidoglycan synthases in growth, cell division and virulence of Listeria monocytogenes.

Authors:  Jeanine Rismondo; Lars Möller; Christine Aldridge; Joe Gray; Waldemar Vollmer; Sven Halbedel
Journal:  Mol Microbiol       Date:  2014-12-19       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.